Details of the Drug

General Information of Drug (ID: DMPDYUS)

Drug Name

IVN-201

Indication

Disease Entry	ICD 11	Status	REF
Allergy	4A80-4A85	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00718679) Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled Trial. U.S.National Institutes of Health.